Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner

被引:126
作者
Casanovas, O
Miró, B
Estanyol, JM
Itarte, E
Agell, N
Bachs, O
机构
[1] Univ Barcelona, Fac Med, Dept Biol Cellular & Anat Patol, Inst Invest Biomed August Pi Sunyer, Barcelona 08036, Spain
[2] Univ Autonoma Barcelona, Fac Ciencies, Dept Bioquim & Biol Mol, Bellaterra, Spain
关键词
D O I
10.1074/jbc.M006324200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here that different cell stresses regulate the stability of cyclin D1 protein. Exposition of Granta 519 cells to osmotic shock, oxidative stress, and arsenite induced the post-transcriptional down-regulation of cyclin D1. In the case of osmotic shock, this effect was completely reversed by the addition of p38(SAPK2)-specific inhibitors (SB203580 or SB220025), indicating that this effect is dependent on p38(SAPK2) activity. Moreover, the use of proteasome inhibitors prevented this down-regulation. Thus, osmotic shock induces proteasomal degradation of cyclin D1 protein by a p38(SAPK2)-dependent pathway. The effect of p38(SAPK2) On cyclin D1 stability might be mediated by direct phosphorylation at specific sites. We found that p38(SAPK2) phosphorylates cyclin D1 in vitro at Thr(286) and that this phosphorylation triggers the ubiquitination of cyclin D1. These results link for the first time a stress-induced MAP kinase pathway to cyclin D1 protein stability, and they will help to understand the molecular mechanisms by which stress transduction pathways regulate the cell cycle machinery and take control over cell proliferation.
引用
收藏
页码:35091 / 35097
页数:7
相关论文
共 56 条
  • [1] TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS
    ALBANESE, C
    JOHNSON, J
    WATANABE, G
    EKLUND, N
    VU, D
    ARNOLD, A
    PESTELL, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23589 - 23597
  • [2] BATES S, 1994, ONCOGENE, V9, P1633
  • [3] Kinetic mechanism of the p38-α MAP kinase:: Phosphoryl transfer to synthetic peptides
    Chen, GJ
    Porter, MD
    Bristol, JR
    Fitzgibbon, MJ
    Pazhanisamy, S
    [J]. BIOCHEMISTRY, 2000, 39 (08) : 2079 - 2087
  • [4] COCKS BG, 1992, J BIOL CHEM, V267, P12307
  • [5] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [6] DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215
  • [7] Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway
    Diehl, JA
    Zindy, F
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 1997, 11 (08) : 957 - 972
  • [8] A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase
    Diehl, JA
    Sherr, CJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) : 7362 - 7374
  • [9] Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization
    Diehl, JA
    Cheng, MG
    Roussel, MF
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (22) : 3499 - 3511
  • [10] Regulation of neuronal survival by the serine-threonine protein kinase Akt
    Dudek, H
    Datta, SR
    Franke, TF
    Birnbaum, MJ
    Yao, RJ
    Cooper, GM
    Segal, RA
    Kaplan, DR
    Greenberg, ME
    [J]. SCIENCE, 1997, 275 (5300) : 661 - 665